tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Adam Vogel, 3 are a BUY (100%).
Analyst Adam Vogel, currently employed at CRAIG HALLUM, carries an average stock price target met ratio of 33.33% that have a potential upside of 147.15% achieved within 150 days.
Adam Vogel’s has documented 6 price targets and ratings displayed on 1 stocks.
Most recent stock forecast was given on IMNM, Immunome at 04-Mar-2026.
Analyst best performing recommendations are on IMNM (IMMUNOME).
The best stock recommendation documented was for IMNM (IMMUNOME) at 9/5/2025. The price target of $26 was fulfilled within 150 days with a profit of $15.48 (147.15%) receiving and performance score of 9.81.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 12-Feb-2026
$40
$19.1 (91.39%)
$40
23 days ago
(10-Sep-2026)
0/2 (0%)
$15.03 (60.19%)
Buy Since 19-Dec-2023
$35
$14.1 (67.46%)
$31
1 months 21 days ago
(12-Aug-2026)
1/9 (11.11%)
$7.01 (25.04%)
20
Buy Since 08-Nov-2024
$30
$10.04 (50.30%)
$33
6 months 29 days ago
(04-Mar-2026)
0/4 (0%)
$7.48 (33.21%)
Buy Since 05-Sep-2025
$36
$16.04 (80.36%)
$33
6 months 29 days ago
(04-Mar-2026)
1/3 (33.33%)
$13.48 (59.86%)
150
Buy Since 22-Aug-2025
$40
$20.04 (100.40%)
$18
9 months 17 days ago
(16-Dec-2025)
1/2 (50%)
$16.52 (70.36%)
87
What Year was the first public recommendation made by Adam Vogel?
